The New England journal of medicine

• Latest
• Best
• Search…

• N. Engl. J. Med. · Jan 2008

  Randomized Controlled Trial

  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  We evaluated capecitabine (an oral fluoropyrimidine) and oxaliplatin (a platinum compound) as alternatives to infused fluorouracil and cisplatin, respectively, for untreated advanced esophagogastric cancer. ⋯ Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer. (Current Controlled Trials number, ISRCTN51678883 [controlled-trials.com].).

  keep reading… or not…

• N. Engl. J. Med. · Jan 2008

  Clinical problem-solving. Failure to respond--a 52-year-old man presented to his primary care physician with dyspnea and cough.

  no abstract available

  read more… mark as read…

• N. Engl. J. Med. · Jan 2008

  Editorial Comment

  Survival after tachyarrhythmic arrest--what are we waiting for?

  no abstract available

  expand abstract… mark as read…